| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |